Charlotte Russell recently joined the MitoCAMB research group as a Research Coordinator for the LifeArc Centre for Rare Mitochondrial Diseases.
Charlotte holds a degree in Microbiology with an Industrial Placement from the University of Manchester and began her career as a Research Assistant at Queen Mary, University of London, working across several microbiology and molecular biology laboratories within the School of Biological and Chemical Sciences.
In 2012, Charlotte moved into clinical trials, joining the Medical Research Council Clinical Trials Unit at University College London as a Trial Manager with laboratory responsibilities. She supported primarily the infectious disease studies in the unit, overseeing sample processing, collection, tracking, and centralisation. In 2017, she became a Clinical Trial Manager on the Strategic Timing of Antiretroviral Treatment (START) trial—a global, multi-centre randomised controlled study across 36 countries, including 20 UK sites, which demonstrated the benefits of early antiretroviral therapy for individuals with HIV.
Charlotte joined Norwich Medical School in 2018 as a Senior Research Associate on the NIHR-funded INHALE programme, which evaluated molecular diagnostics for hospital-acquired and ventilator-associated pneumonia in UK critical care. She contributed across all work packages, supporting the Programme Manager and investigators and led patient and public involvement and engagement (PPIE) group as part of the programme, establishing an inclusive environment to support meaningful participant contributions. The programme was later recognised nationally through the NIHR “Making it Public” campaign as an example of best practice in PPIE.
In 2021, Charlotte moved to the Norwich Clinical Trials Unit as a Clinical Trial Manager, working on studies led by Chief Investigators in the University of Cambridge Department of Clinical Neurosciences.